- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
IND Swift Laboratories Ltd (ISLB)
IND Swift Laboratories Ltd stock price live, this page displays NSE ISLB stock exchange data. View the ISLB premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the IND Swift Laboratories Ltd real time stock price chart below.
What Is the IND Swift Laboratories Ltd Stock Price Today?
The IND Swift Laboratories Ltd stock price today is 405.05.
What Is the Stock Symbol for IND Swift Laboratories Ltd?
The stock symbol for IND Swift Laboratories Ltd is "ISLB."
What Stock Exchange Does IND Swift Laboratories Ltd Trade On?
IND Swift Laboratories Ltd is listed and trades on the NSE stock exchange.
Is IND Swift Laboratories Ltd a Good Stock to Buy?
Determining whether IND Swift Laboratories Ltd, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ISLB quote. (ISIN: INE915B01019)
What Is the IND Swift Laboratories Ltd Stock Price Today?
The IND Swift Laboratories Ltd stock price today is 405.05.
What Is the Stock Symbol for IND Swift Laboratories Ltd?
The stock symbol for IND Swift Laboratories Ltd is "ISLB."
What Stock Exchange Does IND Swift Laboratories Ltd Trade On?
IND Swift Laboratories Ltd is listed and trades on the NSE stock exchange.
Is IND Swift Laboratories Ltd a Good Stock to Buy?
Determining whether IND Swift Laboratories Ltd, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ISLB quote. (ISIN: INE915B01019)
405.05
-0.50(-0.12%)
Closed·
Fair Value
An estimate of a Ind-Swift Labs's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
391.95
412.00
52 wk Range
87.15
417.00
ISLB is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Ind-Swift Labs's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
391.95412.00
52 wk Range
87.15417.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
ISLB Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Ind-Swift Labs's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Earnings
Latest Release
Aug 10, 2026
EPS / Forecast
2.84 / --
Revenue / Forecast
1.91B / --
Compare ISLB to Peers and Sector
Metrics to compare | ISLB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipISLBPeersSector | |
|---|---|---|---|---|
P/E Ratio | 61.6x | 33.2x | −0.4x | |
PEG Ratio | −0.76 | 0.32 | 0.00 | |
Price/Book | 2.6x | 4.4x | 2.6x | |
Price / LTM Sales | 5.2x | 4.0x | 3.1x | |
Upside (Analyst Target) | - | 2.3% | 52.9% | |
Fair Value Upside | Unlock | −4.9% | 6.4% | Unlock |
Ind-Swift Laboratories Limited, together with its subsidiaries, develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, Parkinson’s disease, hyperparathyrodism, analgesic, aromatase inhibitor, nootropic, antidiarrhoeal/antiprotozoal, alcohol abstinence, antineoplastic, ADHD symptoms, anticancer, hypercholesterolemia, antimuscarinic, antimigraine, and thrombocytopenia. It also provides reference standards and impurities for acamprosate calcium, anastrozole, aripiprazole, atorvastatin calcium, azithromycin dihydrate, bexarotene, cinacalcet hydrochloride, clopidogrel bisulphate, clopidogrel hydrochloride, dapoxetine hydrochloride, donepezil hydrochloride, ezetimibe, fexofenadine hydrochloride, imatinib mesylate, ivabradine hydrochloride, ivabradine oxalate, letrozole, mecloxamine citrate, naratriptan hydrochloride, nateglinide, nitazoxanide, nitrosamine, pazopanib hydrochloride, quetiapine hemifumarate, raltegravir potassium, ropinirole hydrochloride, rosuvastatin calcium, saxagliptin monohydrate, silodosin, and temozolomide, as well as contract research and manufacturing services. The company exports its products. Ind-Swift Laboratories Limited was incorporated in 1995 and is based in Manimajra, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Ind-Swift Labs (ISLB) Stock Price Today?
The Ind-Swift Labs stock price today is 405.05 INR.
What Stock Exchange Does Ind-Swift Labs Trade On?
Ind-Swift Labs is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Ind-Swift Labs?
The stock symbol for Ind-Swift Labs is "ISLB."
What Is the Ind-Swift Labs Market Cap?
As of today, Ind-Swift Labs market cap is 35.22B INR.
What Is Ind-Swift Labs's Earnings Per Share (TTM)?
The Ind-Swift Labs EPS (TTM) is 6.47.
From a Technical Analysis Perspective, Is ISLB a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Ind-Swift Labs Stock Split?
Ind-Swift Labs has split 0 times.
How Many Employees Does Ind-Swift Labs Have?
Ind-Swift Labs has 1388 employees.
What is the current trading status of Ind-Swift Labs (ISLB)?
As of Sep 23, 2026, Ind-Swift Labs (ISLB) is trading at a price of 405.05 INR, with a previous close of 405.05 INR. The stock has fluctuated within a day range of 391.95 INR to 412.00 INR, while its 52-week range spans from 87.15 INR to 417.00 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.